Drug Profile
Research programme: dengue vaccine - VaxInnate/University of Texas Medical Branch
Latest Information Update: 11 Sep 2017
Price :
$50
*
At a glance
- Originator University of Texas Medical Branch; VaxInnate
- Class Dengue vaccines
- Mechanism of Action Immunostimulants; Toll-like receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Dengue
Most Recent Events
- 04 Apr 2013 Research programme is still in preclinical trials for Dengue in USA
- 07 May 2009 Preclinical development is ongoing in USA
- 01 Aug 2007 Preclinical trials in Dengue in USA (unspecified route)